Publication:
Oxidized-LDL and Fe3+/ascorbic acid-induced oxidative modifications and phosphatidylserine exposure in human platelets are reduced by melatonin

dc.contributor.authorsSener, A.; Ozsavci, D.; Bingol-Ozakpinar, O.; Cevik, O.; Yanikkaya-Demirel, G.; Yardimci, T.
dc.date.accessioned2022-03-25T19:39:12Z
dc.date.accessioned2026-01-10T16:52:52Z
dc.date.available2022-03-25T19:39:12Z
dc.date.issued2009
dc.description.abstractLow-density lipoprotein (LDL) modifications and platelet activation are major risk factors for cardiovascular diseases. When platelets are exposed to oxidative stress, they become activated. Oxidized LDL (ox-LDL) and metal-catalysed oxidation systems such as Fe3+/ascorbic acid increase free radical production. We wanted to verify whether melatonin has a protective effect against oxidative modifications and phosphatidylserine externalization in platelets induced by ox-LDL and Fe3+/ascorbic acid. For in vitro effects of melatonin on platelets, ADP-activated platelets were incubated with ox-LDL or Fe3+/ascorbic acid for 1 h at 37 degrees C with or without melatonin. Then platelet malondialdehyde, protein carbonyl and glutathione levels were measured. Platelet phosphatidylserine exposure was measured with annexin-V using flow cytometry. Malondialdehyde, protein carbonyl and phosphatidylserine levels of platelets treated with Fe3+/ascorbic acid significantly increased compared to the control group. Glutathione contents of Fe3+/ascorbic acid-treated platelets significantly decreased. Melatonin pre-treatment of Fe3+/ascorbic acid-treated platelets caused a mar ked reduction in malondialdehyde and phosphatidylserine levels and a marked increase in glutathione levels. Melatonin also caused non-significant reduction in protein carbonyl contents of Fe3+/ascorbic acid-treated platelets. Malondialdehyde, protein carbonyl and phosphatidylserine levels of platelets treated with ox-LDL also significantly increased compared to the control group. Platelet glutathione levels non-significantly decreased with ox-LDL. With addition of melatonin, malondialdehyde, protein carbonyl and phosphatidylserine levels of platelets treated with ox-LDL significantly decreased. These data suggest that melatonin may protect platelets from iron overload-induced and ox-LDL-induced oxidative modifications and also from the triggering signals of apoptosis activation, possibly due to its scavenger effect on toxic free radicals.
dc.identifier.issn0015-5500
dc.identifier.pubmedPMID: 19454178
dc.identifier.urihttps://hdl.handle.net/11424/254771
dc.language.isoeng
dc.relation.ispartofFolia Biologica
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAdult
dc.subjectHumans
dc.subjectAntioxidants
dc.subjectMelatonin
dc.subjectGlutathione
dc.subjectLipid Peroxidation
dc.subjectMalondialdehyde
dc.subjectOxidative Stress
dc.subjectOxidation-Reduction
dc.subjectLipoproteins, LDL
dc.subjectBlood Platelets
dc.subjectAscorbic Acid
dc.subjectFerric Compounds
dc.subjectPhosphatidylserines
dc.titleOxidized-LDL and Fe3+/ascorbic acid-induced oxidative modifications and phosphatidylserine exposure in human platelets are reduced by melatonin
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage52
oaire.citation.startPage45
oaire.citation.titleFolia Biologica
oaire.citation.volume2

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
149.3 KB
Format:
Adobe Portable Document Format